Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The IMPACT SHPT Study: Study to Evaluate the Improved Management of iPTH With Paricalcitol-centered Therapy vs. Cinacalcet Therapy With Low-dose Vitamin D in Hemodialysis Patients With Secondary Hyperparathyroidism

NCT00977080 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00977080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00977080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The IMPACT SHPT Study: Study to Evaluate the Improved Management of iPTH With Paricalcitol-centered Therapy vs. Cinacalcet Therapy With Low-dose Vitamin D in Hemodialysis Patients With Secondary Hyperparathyroidism
Lead sponsor
Abbott
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2009
Completion date
May 31, 2011
Enrollment
272 (actual)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, hemodialysis, secondary hyperparathyroidism